Skip to content

Prognostic Value of Number of Metastatic Nodes in School-Age Children and Adolescents With Papillary Thyroid Cancer: A Real-Life Multicenter Study.

Jul 2026 · Clinical Nuclear Medicine · Vol 51, pp. 791-797 · 0 citations · 25 references
Medicine

TL;DR

The number of metastatic nodes is a predominant factor associated with persistent disease, and incorporating quantitative assessment of metastatic nodes may improve risk stratification in SACAs with N1b PTC.

Abstract

Background

How metastatic nodal burden influences the prognosis of school-age children and adolescents (SACAs) with papillary thyroid cancer (PTC) remains unclear. We investigated the independent impact of numerical metastatic nodal burden on clinical outcomes in these patients.

Materials And Methods

This multicenter retrospective cohort study included SACAs with PTC aged 18 years and older who had undergone total thyroidectomy and radioiodine therapy across 12 nuclear medicine departments in China. Persistent biochemical and structural diseases were evaluated. The independent role of metastatic nodes in persistent disease was evaluated using Cox proportional hazards regression.

Results

In total, 486 SACAs with PTC were analyzed, of whom 115 had N1a and 371 had N1b. Among SACAs with N1b PTC, a higher number of metastatic lymph nodes, analyzed as a continuous variable, was identified as an independent risk factor for persistent structural disease (HR: 1.06; 95% CI: 1.01-1.11). When analyzed as a categorical variable, patients in the third (16-22 nodes) and fourth (>22 nodes) quartiles of the number of metastatic nodes exhibited an increased hazard of persistent structural disease (HR: 3.35; 95% CI: 1.13-9.97; P=0.029 and HR: 5.52; 95% CI: 1.59-19.13; P=0.007, respectively). ROC analysis identified a cutoff of ≥14 metastatic lymph nodes for predicting persistent structural diseases. However, for SACAs with N1a PTC, analysis of the number of metastatic nodes revealed no association with persistent disease.

Conclusions

The number of metastatic nodes is a predominant factor associated with persistent disease, and incorporating quantitative assessment of metastatic nodes may improve risk stratification in SACAs with N1b PTC.

View source

Similar papers

Open access Jul 2026

Distant lymph node metastasis in head and neck cancer: incidence, predictors, and survival outcomes in a population-based cohort

Background Distant lymph node metastasis (DLM) is rare in head and neck cancer (HNC), occurring in only 0.76% of cases, underscoring the importance of understanding its clinical behavior. However, population-based data on the incidence, predictors, and prognostic implications of DLM relative to other metastatic pattern...

Jian-Lin Yue, Da-Yu Liu, Rui-Jie Sun et al. · 0 citations
Open access Aug 2026

TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma.

The findings of this cohort study suggest that the high prevalence of TERT promoter variants in older patients largely explains the association between age and worse prognosis in PTC.

V. R. Marczyk, Sophie Li, Chia C. Wu et al. · 0 citations
Open access Aug 2026

Association of Metastatic Lymph Node Count and Primary Tumor Size with Disease-Free Survival in Stage II–III Gastric Cancer: A Retrospective Cohort Study

Background and Objectives: The relative prognostic information provided by different nodal metrics and the independent role of primary tumor size remain unclear in gastric cancer. This study evaluated the association of metastatic lymph node count and primary tumor size with disease-free survival (DFS) in stage II–III...

Emine Kanatsız, Yasin Sezgin, Yonca Yılmaz Ürün · 0 citations
Open access Aug 2026

Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From Turkey

Background Obesity has been associated with adverse outcomes in several malignancies; however, the prognostic significance of body mass index (BMI) in metastatic cervical cancer remains unclear because of limited and conflicting evidence. This study aimed to evaluate the impact of BMI on progression-free survival (PFS)...

Rumeysa Çolak, C. Kapar, S. Tacar et al. · 0 citations
Open access Aug 2026

Predictive Factors of Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer: A Retrospective Study of 525 Patients

Background: Non-muscle-invasive bladder cancer (NMIBC) is characterized by high recurrence rates and variable progression risks. Identifying predictive factors, including socioeconomic determinants, is essential for optimizing the management of this condition.Methods: We conducted a retrospective monocentric study of 5...

R. Es-saady, S. Lafdali, Adnane Mortaji et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.